BFM
EXAS

Boothbay Fund Management’s Exact Sciences EXAS Stock Holding History

Boothbay Fund Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-241
Closed -$3.18M – 1924
2021
Q1 		$3.18M Buy
+241
New +$33K 0.12% 189

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Boothbay Fund Management's EXAS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 66,782 shares — an estimated $6.78M sold.

Boothbay Fund Management first reported a position in EXAS in Q4 2020 and held it in 3 quarters. The position peaked at $22.8M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Boothbay Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 66,782 Exact Sciences shares in Q1 2026, an estimated $6.78M.
  • Boothbay Fund Management first reported a position in Exact Sciences in Q4 2020 and held it in 3 quarters.
  • Boothbay Fund Management's Exact Sciences position peaked at $22.8M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.